[Knockdown of LSD1 promotes differentiation of human induced pluripotent stem cells into insulin-producing cells in vitro].
Objective To investigate a protocol for the efficient differentiation of human induced pluripotent stem cells (hiPSCs) into insulin-producing cells (IPCs) in vitro. Methods Lysine-specific demethylase 1 (LSD1) gene was knocked down in hiPSCs by RNAi. A four-step method was performed to induce the differentiation of hiPSCs into IPCs. The differentiation efficiency of IPCs was analyzed by flow cytometry. Real-time quantitative PCR was used to detect the mRNA levels of LSD1, OCT4, SOX17, FOXA2, PDX1, PAX4, PAX6, HNF6, TCF1, NKX6.1, GLUT2, GK, insulin and MAFA. The expression and localization of PDX1 and insulin were determined by immunofluorescence technique. DTZ staining and transmission electron microscopy were used to observe the secretion and distribution of intracellular insulin-containing granules in IPCs. In addition, the yield of insulin and C-peptide of IPCs were tested by ELISA. Results Compared with the control, the LSD1 knockdown group showed a higher differentiation efficiency of IPCs and the mRNA expression of pancreatic islet β-cell development-related genes SOX17, PDX1, PAX4 and insulin were significantly up-regulated. IPCs from the LSD1 knockdown group co-expressed mature β-cell specific markers PDX1 and insulin. In the LSD1 knockdown group, IPCs released insulin as secretory vesicles in response to glucose stimuli, and the yield of insulin or C-peptide reached 1/6 of adult human islets (only 1/8 in the control group). Conclusion Knockdown of LSD1 can promote the efficient differentiation of hiPSCs into IPCs in vitro.